123 related articles for article (PubMed ID: 1680431)
1. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
Klein JR; Grunewald RW; Steffgen J; Franz HE
Adv Perit Dial; 1991; 7():225-9. PubMed ID: 1680431
[TBL] [Abstract][Full Text] [Related]
2. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
[TBL] [Abstract][Full Text] [Related]
3. Clearance of osteocalcin by peritoneal dialysis in children with end-stage renal disease.
Gundberg CM; Hanning RM; Liu YA; Zlotkin SH; Balfe JW; Cole DE
Pediatr Res; 1987 Mar; 21(3):296-300. PubMed ID: 3494227
[TBL] [Abstract][Full Text] [Related]
4. [Selected parameters of bone metabolism in hemodialyzed and peritoneally dialyzed patients].
Małyszko J; Zbroch E; Wołczyński S; Myśliwiec M
Przegl Lek; 2000; 57(12):711-3. PubMed ID: 11398592
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
6. Serum levels and peritoneal loss of prolactin in CAPD patients.
Kagan A; Gertler A; Ulman M; Bar-Khayim Y
Adv Perit Dial; 1991; 7():247-52. PubMed ID: 1680437
[TBL] [Abstract][Full Text] [Related]
7. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
Joffe P; Heaf JG; Jensen LT
Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
[TBL] [Abstract][Full Text] [Related]
8. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
Motz W
Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal clearance of biochemical markers of bone turnover in children with end stage renal failure on peritoneal dialysis.
Bayazit AK; Cengiz N; Anarat R; Noyan A; Anarat A
Turk J Pediatr; 2006; 48(2):140-2. PubMed ID: 16848114
[TBL] [Abstract][Full Text] [Related]
10. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
12. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
13. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD.
Macia M; Coronel F; Navarro JF; Gallego E; Herrero JA; Méndez ML; Chahin J; García J
Clin Nephrol; 1997 Sep; 48(3):181-4. PubMed ID: 9342490
[TBL] [Abstract][Full Text] [Related]
14. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
[TBL] [Abstract][Full Text] [Related]
15. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
[TBL] [Abstract][Full Text] [Related]
16. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
17. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
19. Serum and effluent lysozyme (muramidase) activity in CAPD patients.
Kagan A; Bar-Khayim Y; Yaari A; Fainaru M; Resnitzky P
Adv Perit Dial; 1989; 5():154-6. PubMed ID: 2577400
[TBL] [Abstract][Full Text] [Related]
20. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
